Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy
Launched by EMORY UNIVERSITY · May 6, 2019
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
There are multiple choices for a surgeon and their patient when it comes to weight loss surgery. One of those options is a procedure called a "laparoscopic sleeve gastrectomy" (LSG). In this procedure the majority of the patient's stomach is removed leaving behind a stapled "sleeve" about the same size as the patient's esophagus.
During this procedure there are three main devices that surgeon inserts through the mouth and in to the stomach to calibrate the size of the "sleeve". They can use a standard weighted bougie, an endoscope, or a suction calibration device. This study aims to compar...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years old or older
- • agreed with a surgeon that laparoscopic sleeve gastrectomy (LSG) is the best choice
- Exclusion Criteria:
- • Had prior gastric surgery or bariatric surgery (including prior adjustable gastric band and/or sleeve gastrectomy)
- • Concomitant hiatal surgery
- • Paraesophageal hernia at time of surgery
- • Any subject with prescribed immunosuppressive drugs.
- • In the opinion of investigator, subject is not eligible to participate in the study.
- • If patient is a female and becomes pregnant at any time during the study duration
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Patients applied
Trial Officials
Elizabeth Hechenbleikner, MD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials